Patrick J. Christmas
CIK 1521123 · Chief Strategy & Legal Officer · last filed 2026-02-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.40M
Companies
2
Total Filings
37
Lifetime Open-Market Net
-$6.41M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Strategy & Legal Officer | 210,667 | $6.66 | $1.40M | -$6.41M | 32 | 2026-02-03 |
| K-V Pharmaceutical Co (KV.B) Delisted | General Counsel | — | — | — | $0 | 3 | 2012-03-30 |
Recent Filings · Page 4 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-06 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2016-08-22 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2013-10-04 | — | Grant (A) | — | $0 | |
| 2013-09-24 | — | Other (J) | — | $0 | |
| 2012-03-30 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-06-03 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-18 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–37 of 37
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.